Abstract:Background: Enterococcus faecalis (Ef) infections are becoming dreadfully common in hospital environments. Infections caused by Ef are difficult to treat because of its acquired resistance to different class of antibiotics, making it a multidrug resistant bacteria. Key pathogenic factor of Ef includes its ability to form biofilm on the surface of diagnostic and other medical devices. Sortase A (SrtA) is a cysteine transpeptidase which plays a pivotal role in the formation of biofilm in Ef, hence, it is considered as an important enzyme for the pathogenesis of Ef. Thus, inhibition of (SrtA) will affect biofilm formation, which will reduce its virulence and eventually Ef infection will be abridged. Objective: To find potential inhibitors of Enterococcus faecalis Sortase A (EfSrtA) through insilico and in-vitro methods. Methods: Gene coding for EfSrtA was cloned, expressed and purified. Three-dimensional model of EfSrtA was created using Swiss-Model workspace. In-silico docking studies using Autodock vina and molecular dynamics simulations of the modelled structures using Gromacs platform were performed to explore potential lead compounds against EfSrtA. In-vitro binding experiments using spectrofluorometric technique was carried out to confirm and validate the study. Results: In-silico docking and in-vitro binding experiments revealed that curcumin, berberine and myricetin bound to EfSrtA at nanomolar concentrations with high affinity. Conclusion: This is a first structural report of EfSrtA with curcumin, berberine and myricetin. Taking in account the herbal nature of these compounds, the use of these compounds as inhibitors will be advantageous. This study validated curcumin, berberine and myricetin as potential inhibitors of EfSrtA.

Synthesis, Biological Evaluation and Molecular Docking Analysis of 2-Phenyl-benzofuran-3-carboxamide Derivatives As Potential Inhibitors of Staphylococcus Aureus Sortase A

Synthesis, Biological Evaluation and Molecular Docking of 2-Phenyl-benzo[d]oxazole-7-carboxamide Derivatives As Potential Staphylococcus Aureus Sortase A Inhibitors

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A Inhibitors

Novel Inhibitor Discovery of Staphylococcus Aureus Sortase B and the Mechanism Confirmation Via Molecular Modeling.

NMR Structure‐based Optimization of Staphylococcus Aureus Sortase A Pyridazinone Inhibitors

Antiinfective Therapy with a Small Molecule Inhibitor of Staphylococcus Aureus Sortase.

QSAR Studies on a Class of Benzofuranene Cyanide Derivatives as Potential Inhibitors Targeting Staphylococcus aureus Sortase A

In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation

Biological and Biophysical Methods for Evaluation of Inhibitors of Sortase A in Staphylococcus aureus: An Overview

The Discovery of Novel Agents Against Staphylococcus Aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation.

Synthesis, Antimicrobial Activities, and Molecular Modeling Studies of Agents for the Sortase A Enzyme

Molecular Modelling Reveals the Inhibition Mechanism and Structure–activity Relationship of Curcumin and Its Analogues to Staphylococcal Aureus Sortase A

Oligopeptide Targeting Sortase A as Potential Anti-infective Therapy for Staphylococcus aureus .

The Complete Assessment of Small Molecule and Peptidomimetic Inhibitors of Sortase A Towards Antivirulence Treatment

Quinone Skeleton As a New Class of Irreversible Inhibitors Against Staphylococcus Aureus Sortase A.

Prospecting Potential Inhibitors of Sortase A from Enterococcus faecalis: A Multidrug Resistant Bacteria, through In-silico and In-vitro Approaches

Erianin Against Staphylococcus Aureus Infection Via Inhibiting Sortase A

Exploring the modulatory impact of isosakuranetin on Staphylococcus aureus: Inhibition of sortase A activity and α-haemolysin expression

Molecular Mechanism of the Flavonoid Natural Product Dryocrassin ABBA against Staphylococcus aureus Sortase A.